Amir Elstein - Jun 6, 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role: Director
Signature: /s/ Dov Bergwerk as attorney-in-fact for Amir Elstein
Stock symbol: TEVA
Transactions as of: Jun 6, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/10/2024, 07:33 AM
Previous filing: Aug 7, 2023
Next filing: Jun 17, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TEVA	Restricted Share Units	Award	$0	+9.63K		$0.00	9.63K	Jun 6, 2024	Ordinary Shares	9.63K		Direct	F1, F2, F3

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2	Restricted share units were granted on June 6, 2024 and vest on June 6, 2025.
F3	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.